AI Science Tracker

Virtual screening identifies antiplasmodial beta-haematin inhibitor chemotypes

University of Cape Town · 14 Feb 2023 · medicine

Discovery

Virtual screening identifies antiplasmodial beta-haematin inhibitor chemotypes

Molecular docking and Bayesian/SVM classifiers screened a ChemDiv 300k library. Researchers tested prioritized commercial compounds and reported coumarin and iminodipyridinopyrimidine chemotypes active against beta-haematin and whole-cell P. falciparum, including chloroquine-resistant parasites. This is one bounded in-vitro campaign, not clinical evidence.

Technology: Bayesian and support-vector classifiers; molecular docking

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Primary abstract reports prioritized compounds with beta-haematin and whole-cell parasite activity.
  • Still unknown: A 2023 conference abstract may disclose an early coumarin result; the article’s specific two-chemotype campaign is retained without priority claim; no clinical evidence.
  • AI role: Sequential ligand/structure virtual screening prioritizes commercial compounds for biochemical and parasite assays.

Evidence sources: https://doi.org/10.1038/s41598-023-29273-w

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 16 Nov 2026. Review scope: PMC-hosted primary full article; PubMed primary record/abstract. Material checked for the specific claims stated in the record..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.